Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58
Authors:
Open Access
- 24 February 2010
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 91 (7) , 1834-1839
Abstract
Human papillomavirus (HPV) 58 is a high-risk HPV type associated with progression to invasive genital carcinomas. We developed six monoclonal antibodies (mAbs) against HPV58 L1 virus-like particles that bind conformational epitopes on HPV58. The hybridoma cell lines were adapted to serum- and animal component-free conditions and the mAb supernatants were affinity-purified. The six mAbs neutralized HPV58 pseudoviruses (PsVs) and ‘quasivirions’ with different capacities. The mAbs differed in their ability to prevent PsV58 attachment to HaCaT cells, to the extracellular matrix (ECM) deposited by HaCaT cells, to heparin and to purified human laminin 5, a protein in the ECM. These mAbs provide a unique set of tools to study the binding properties of a previously untested, high-risk HPV type and the opportunity to compare these characteristics with the binding of other HPV types.Keywords
This publication has 32 references indexed in Scilit:
- Differential binding patterns to host cells associated with particles of several human alphapapillomavirus typesJournal of General Virology, 2009
- Cervical Human Papillomavirus Incidence and Persistence in a Cohort of HIV-Negative Women in ZimbabweSexually Transmitted Diseases, 2009
- Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human PapillomavirusJournal of Virology, 2009
- Inhibition of Transfer to Secondary Receptors by Heparan Sulfate-Binding Drug or Antibody Induces Noninfectious Uptake of Human PapillomavirusJournal of Virology, 2007
- Human Papillomavirus Type 31 Uses a Caveolin 1- and Dynamin 2-Mediated Entry Pathway for Infection of Human KeratinocytesJournal of Virology, 2007
- Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of InhibitionJournal of Virology, 2007
- Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particlesVirology, 2007
- Preclinical Model To Test Human Papillomavirus Virus (HPV) Capsid Vaccines In Vivo Using Infectious HPV/Cottontail Rabbit Papillomavirus Chimeric Papillomavirus ParticlesJournal of Virology, 2006
- Keratinocyte-Secreted Laminin 5 Can Function as a Transient Receptor for Human Papillomaviruses by Binding Virions and Transferring Them to Adjacent CellsJournal of Virology, 2006
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003